Santosh S. Kulkarni - Concepedia

Author

Santosh S. Kulkarni

National Institute on Drug Abuse

Also Known As

Kulkarni, Santosh S., Santosh Kulkarni, Santosh S Kulkarni, Santosh S. Kulkarni, Santosh Sanjeev Kulkarni

Publications

970

Citations

H-Index

Concepts

All Affiliations

National Institute on Drug Abuse University of Mumbai Syngene International (India)University of Kansas National Institutes of Health

About

Santosh S. Kulkarni is an author at National Institute on Drug Abuse specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	416
2	Biochemistry	11	11	377
3	Natural Sciences	6	6	217
4	Biomolecular Engineering	2	2	57
5	Engineering	1	1	31

Santosh S. Kulkarni

Publications

850

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (−)- and (+)-Tetrahydrofurobenzofuran and Methanobenzodioxepine Weiming Luo, Qian‐sheng Yu, Santosh S. Kulkarni, Journal of Medicinal Chemistry	2006	77
Fragment-Based Discovery of New Highly Substituted 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]- and 3<i>H</i>-Imidazolo[4,5-<i>b</i>]-Pyridines as Focal Adhesion Kinase Inhibitors Timo Heinrich, Jeyaprakashnarayanan Seenisamy, Lourdusamy Emmanuvel, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetMolecular BiologyChemical BiologyPharmaceutical Chemistry	2013	70
Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists Santosh S. Kulkarni, Amy Hauck Newman Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityMedicineRational Drug DesignHeterobicyclic Templates	2007	62
Three-Dimensional Quantitative Structure−Activity Relationship of Interleukin 1-β Converting Enzyme Inhibitors: A Comparative Molecular Field Analysis Study Santosh S. Kulkarni, Vithal M. Kulkarni Journal of Medicinal Chemistry	1999	60
Novel Anticholinesterases Based on the Molecular Skeletons of Furobenzofuran and Methanobenzodioxepine Weiming Luo, Qian‐sheng Yu, Ming Zhan, Journal of Medicinal Chemistry Molecular SkeletonsBioorganic ChemistrySeries Novel CarbamatesBiochemistryAntiparasitic Agent	2005	55
Recognition of Benztropine by the Dopamine Transporter (DAT) Differs from That of the Classical Dopamine Uptake Inhibitors Cocaine, Methylphenidate, and Mazindol as a Function of a DAT Transmembrane 1 Aspartic Acid Residue Okechukwu Ukairo, Corry D. Bondi, Amy Hauck Newman, Journal of Pharmacology and Experimental Therapeutics	2005	47
Structure−Activity Relationships Comparing <i>N</i>-(6-Methylpyridin-yl)-Substituted Aryl Amides to 2-Methyl-6-(substituted-arylethynyl)pyridines or 2-Methyl-4-(substituted-arylethynyl)thiazoles as Novel Metabotropic Glutamate Receptor Subtype 5 Antagonists Santosh S. Kulkarni, Mu‐Fa Zou, Jianjing Cao, Journal of Medicinal Chemistry	2009	41
Structure−Activity Relationships at Monoamine Transporters for a Series of N-Substituted 3α-(Bis[4-fluorophenyl]methoxy)tropanes: Comparative Molecular Field Analysis, Synthesis, and Pharmacological Evaluation Santosh S. Kulkarni, Peter Grundt, Theresa Kopajtic, Journal of Medicinal Chemistry Molecular PharmacologyPharmaceutical ScienceDrug TargetPharmaceutical ChemistryPharmacological Study	2004	39
Unexpected Opioid Activity Profiles of Analogues of the Novel Peptide Kappa Opioid Receptor Ligand CJ‐15,208 Jane V. Aldrich, Santosh S. Kulkarni, Sanjeewa N. Senadheera, ChemMedChem	2011	35
Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents Santosh S. Kulkarni, Lalji K. Gediya, Vithal M. Kulkarni Bioorganic & Medicinal Chemistry BiochemistryMedicineRational Drug DesignAntihyperglycemic AgentsPharmacology	1999	35

Page 1